"Ohio State Nisonger Center is a research and patient care facility focused on developing programs for people with neurological disorders with the goal of improving quality of life."

During the past decade, The Ohio State University Nisonger Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 9 clinical trials were completed, i.e. on average, 225% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Ohio State University Nisonger Center" #1 sponsor was "Ohio State University" with 5 trials, followed by "Shire" with 3 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored, "Sunovion" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Ohio State University Nisonger Center" #1 collaborator was "National Institute of Mental Health (NIMH)" with 4 trials as a collaborator, "Otsuka America Pharmaceutical" with 2 trials as a collaborator, "Autism Intervention Research Network on Physical Health" with 1 trials as a collaborator, "Autism Treatment Network" with 1 trials as a collaborator and "Brain Resource Center" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "The Ohio State University Nisonger Center" are "Attention-deficit/Hyperactivity Disorder" (3 trials), "Autism Spectrum Disorder" (3 trials), "Autism" (2 trials), "Autistic Disorder" (2 trials) and "Behavioral Symptoms" (2 trials). Many other conditions were trialed in "The Ohio State University Nisonger Center" in a lesser frequency.

Most popular intervention types in "The Ohio State University Nisonger Center" are "Drug" (12 trials), "Device" (2 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Aripiprazole" (3 trials), "Lisdexamfetamine dimesylate" (2 trials), "Methylphenidate Hydrochloride" (2 trials) and "Risperidone" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Ohio State University Nisonger Center" are 16 trials for "All" genders.

Currently, there are NaN active trials in "The Ohio State University Nisonger Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in The Ohio State University Nisonger Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Ohio State University Nisonger Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 3 trials that are defined as “Not Applicable".